Use of antibiotic-impregnated hydroxyapatite for infection following total knee arthroplasty

References

• Lichstein P, Gehrke T, Lombardi A, Romano C, Stockley I, Babis G, et al. One-stage vs two-stage exchange. J Arthroplasty. 2014;29(2):108–11.
   PubMedGoogle Scholar
• Abdel MP, Barreira P, Battenberg A, Berry DJ, Blevins K, Font-Vizcarra L, et al. Hip and knee section, treatment, two-stage exchange spacer-related: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty. 2019;34(2S):S427–S38.
   PubMedGoogle Scholar
• Voleti PB, Baldwin KD, Lee GC. Use of static or articulating spacers for infection following total knee arthroplasty: a systematic literature review. J Bone Joint Surg Am. 2013;95(17):1594–9.
   PubMedGoogle Scholar
• Guild GN, 3rd, Wu B, Scuderi GR. Articulating vs. static antibiotic impregnated spacers in revision total knee arthroplasty for sepsis. A systematic review. J Arthroplasty. 2014;29(3):558–63.
   PubMed Web of Science ®Google Scholar
• Pivec R, Naziri Q, Issa K, Banerjee S, Mont MA. Systematic review comparing static and articulating spacers used for revision of infected total knee arthroplasty. J Arthroplasty. 2014;29(3):553–7.
   PubMed Web of Science ®Google Scholar
• Charette RS, Melnic CM. Two-stage revision arthroplasty for the treatment of prosthetic joint infection. Curr Rev Musculoskelet Med. 2018;11(3):332–40.
   PubMed Web of Science ®Google Scholar
• Faschingbauer M, Reichel H, Bieger R, Kappe T. Mechanical complications with one hundred and thirty eight (antibiotic-laden) cement spacers in the treatment of periprosthetic infection after total hip arthroplasty. Int Orthop. 2015;39(5):989–94.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick DK, Trachtenberg LS, Mangino PD, Von Fraunhofer JA, Seligson D. In vitro characteristics of tobramycin-PMMA beads: compressive strength and leaching. Orthopedics. 1985;8(9):1130–3.
   PubMed Web of Science ®Google Scholar
• Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br. 1992;74(4):600–4.
   PubMedGoogle Scholar
• Brien WW, Salvati EA, Klein R, Brause B, Stern S. Antibiotic impregnated bone cement in total hip arthroplasty. An in vivo comparison of the elution properties of tobramycin and vancomycin. Clin Orthop Relat Res. 1993;296:242–8.
   PubMedGoogle Scholar
• Cerretani D, Giorgi G, Fornara P, Bocchi L, Neri L, Ceffa R, et al. The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study. J Arthroplasty. 2002;17(5):619–26.
   PubMed Web of Science ®Google Scholar
• Sudo A, Hasegawa M, Fukuda A, Uchida A. Treatment of infected hip arthroplasty with antibiotic-impregnated calcium hydroxyapatite. J Arthroplasty. 2008;23(1):145–50.
   PubMed Web of Science ®Google Scholar
• Choe H, Inaba Y, Kobayashi N, Miyamae Y, Ike H, Saito T. Clinical utility of antibiotic-loaded hydroxyapatite block for treatment of intractable periprosthetic joint infection and septic arthritis of the hip. Mod Rheumatol. 2015;25(6):937–42.
   PubMed Web of Science ®Google Scholar
• Uchida A, Shinto Y, Araki N, Ono K. Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic. J Orthop Res. 1992;10(3):440–5.
   PubMed Web of Science ®Google Scholar
• Korkusuz F, Uchida A, Shinto Y, Araki N, Inoue K, Ono K. Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites. J Bone Joint Surg Br. 1993;75(1):111–4.
   PubMed Web of Science ®Google Scholar
• Feldman DS, Lonner JH, Desai P, Zuckerman JD. The role of intraoperative frozen sections in revision total joint arthroplasty. J Bone Joint Surg Am. 1995;77(12):1807–13.
   PubMedGoogle Scholar
• Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989;248:13–4.
   PubMed Web of Science ®Google Scholar
• Kubista B, Hartzler RU, Wood CM, Osmon DR, Hanssen AD, Lewallen DG. Reinfection after two-stage revision for periprosthetic infection of total knee arthroplasty. Int Orthop. 2012;36(1):65–71.
   PubMed Web of Science ®Google Scholar
• Mortazavi SM, Vegari D, Ho A, Zmistowski B, Parvizi J. Two-stage exchange arthroplasty for infected total knee arthroplasty: predictors of failure. Clin Orthop Relat Res. 2011;469(11):3049–54.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Whitehouse MR, Lenguerrand E, Blom AW, Beswick AD. Re-infection outcomes following one- and two-stage surgical revision of infected knee prosthesis: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0151537.
   PubMed Web of Science ®Google Scholar
• Rubinstein E, Keynan Y. Vancomycin revisited - 60 years later. Front Public Health. 2014;2:217.
   PubMedGoogle Scholar
• Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–e55.
   PubMed Web of Science ®Google Scholar
• Petis SM, Perry KI, Mabry TM, Hanssen AD, Berry DJ, Abdel MP. Two-stage exchange protocol for periprosthetic joint infection following total knee arthroplasty in 245 knees without prior treatment for infection. J Bone Joint Surg Am. 2019;101:239–49.
   PubMed Web of Science ®Google Scholar
• Citak M, Argenson JN, Masri B, Kendoff D, Springer B, Alt V, et al. Spacers. J Arthroplasty. 2014;29(2):93–9.
   PubMedGoogle Scholar